Please assess the completion status of the following clinical trial:

Trial Title: Breast Displacement and CT Radiation Dose

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* scheduled for CT of the abdomen and pelvis at Harborview Medical Center~* able to provide written informed consent~Exclusion Criteria:~* Inability to provide written consent for self (minor, intubated, sedated, mentally incapacitated, in excessive physical distress)~* Chest or breast surgery within the previous 8 weeks~* Breast implants~* Open wounds to the chest wall~* Fractures of the ribs or spine within the previous 3 months~* Patients requiring oxygen therapy~* Mastectomy~* Breast radiation therapy~* Scarring to the breasts which would prevent displacement~* Claustrophobia is not an absolute exclusion criterion, but patient comfort will be a primary concern.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Standard CT (Type: NO_INTERVENTION): Women assigned to undergo CT using the standard dose reduction methods (including bismuth shielding and tube current modulation) but without the Chrysalis device.
- Chrysalis CT (Type: EXPERIMENTAL): Women assigned to undergo CT using the standard dose reduction methods (including bismuth shielding and tube current modulation) plus application of the Chrysalis device for breast displacement.

Based on this trial design, predict the completion outcome and termination type (if applicable).